Connection

Milena Gianfrancesco to Janus Kinase Inhibitors

Back to Details
This is a "connection" page, showing publications Milena Gianfrancesco has written about Janus Kinase Inhibitors.
Milena Gianfrancesco
Connection Strength
0.137
Janus Kinase Inhibitors
  1. Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry. Ann Rheum Dis. 2020 07; 79(7):859-866.
    View in: PubMed
    Score: 0.137
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.